Alebund Pharma Buys Back 6,600 H-Shares; Outstanding Float Marginally Trimmed

Bulletin Express11-05 22:20

Alebund Pharmaceuticals (Jiangsu) Limited repurchased 6,600 H-shares on 5 November 2026 via on-market transactions, paying a volume-weighted average price of HKD 17.48 per share. The highest and lowest prices paid were HKD 17.64 and HKD 17.29 respectively, with total consideration amounting to HKD 0.12 million.

Following the transaction, the company’s outstanding share count (excluding treasury shares) fell by 0.0028 % to 235.48 million. Treasury shares increased to 151,200, leaving total issued shares unchanged at 235.64 million.

The buyback was executed under a mandate granted on 14 August 2026 that authorises the company to repurchase up to 23.56 million shares. Aggregate repurchases to date stand at 151,200 shares, representing 0.0642 % of the issued share base at the time the mandate was approved.

Pursuant to Hong Kong Stock Exchange rules, a 30-day moratorium on new share issues or sales of treasury shares is in effect until 5 December 2026. The company confirmed that all repurchases complied with Main Board requirements and that no material changes have been made to the previously filed explanatory statement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment